{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:04:30Z","timestamp":1791345870890,"version":"4.3.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.msard.2024.105535","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T15:37:01Z","timestamp":1709480221000},"page":"105535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Seizures in inflammatory demyelinating disorders of the central nervous system"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-5596","authenticated-orcid":false,"given":"\u00d6zdem","family":"Ert\u00fcrk \u00c7etin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130pek","family":"G\u00fcng\u00f6r Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dcmit","family":"Zanapalio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyzullah","family":"Yadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damla","family":"\u00c7etinkaya Tezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msard.2024.105535_bib0001","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/1550059417693732","article-title":"Status epilepticus and multiple sclerosis: A case presentation and literature review","volume":"49","author":"Atmaca","year":"2018","journal-title":"Clin. EEG Neurosci."},{"issue":"3","key":"10.1016\/j.msard.2024.105535_bib0002","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"24","key":"10.1016\/j.msard.2024.105535_bib0003","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1212\/WNL.0000000000004740","article-title":"Epilepsy in multiple sclerosis: A nationwide population-based register study","volume":"89","author":"Burman","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105535_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101390","article-title":"Epilepsy in multiple sclerosis as a network disease","volume":"36","author":"Bustuchina Vlaicu","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2024.105535_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jnnp-2011-300414","article-title":"Cortical pathology in multiple sclerosis patients with epilepsy: A 3 Year longitudinal study","volume":"83","author":"Calabrese","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"1","key":"10.1016\/j.msard.2024.105535_bib0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458510382246","article-title":"Multiple sclerosis and epileptic seizures","volume":"17","author":"Catenoix","year":"2011","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.msard.2024.105535_bib0007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy & Behavior: E&B"},{"issue":"2","key":"10.1016\/j.msard.2024.105535_bib0008","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/ene.13821","article-title":"Epilepsy and associated mortality in patients with multiple sclerosis","volume":"26","author":"Chou","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.105535_bib0009","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.neurol.2020.08.011","article-title":"Seizure incidence among neuromyelitis optica spectrum disorder patients","volume":"177","author":"Etemadifar","year":"2021","journal-title":"Rev. Neurol. (Paris)"},{"issue":"4","key":"10.1016\/j.msard.2024.105535_bib0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE Official Report: A practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.msard.2024.105535_bib0011","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.seizure.2021.07.009","article-title":"Predictive factors of status epilepticus and its recurrence in patients with adult\u2013onset seizures: A multicenter, long follow\u2013up cohort study","volume":"91","author":"Gasparini","year":"2021","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.msard.2024.105535_bib0012","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/13524585211046739","article-title":"Epilepsy as a predictor of disease progression in multiple sclerosis\u201d","volume":"28","author":"Grothe","year":"2022","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2024.105535_bib0013","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200034","article-title":"Seizure semiology in antibody-associated autoimmune encephalitis","volume":"9","author":"Kaaden","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.msard.2024.105535_bib0014","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1528-1167.2008.01565.x","article-title":"Seizures in multiple sclerosis","volume":"49","author":"Koch","year":"2008","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.msard.2024.105535_bib0015","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00415-019-09332-x","article-title":"Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center","volume":"266","author":"Langenbruch","year":"2019","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2024.105535_bib0016","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1007\/s00415-021-10600-y","article-title":"Occurrence of status epilepticus in persons with epilepsy is determined by sex, epilepsy classification, and etiology: A single center cohort study","volume":"268","author":"Langenbruch","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.105535_bib0017","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroscience.2017.01.035","article-title":"Chronic Demyelination-Induced Seizures","volume":"346","author":"Lapato","year":"2017","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.msard.2024.105535_bib0018","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/epi.17315","article-title":"Seizures and epilepsy in multiple sclerosis, Aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"63","author":"Li","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.msard.2024.105535_bib0019","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.seizure.2021.09.011","article-title":"Seizures in myelin oligodendrocyte glycoprotein antibody-associated disorders and related immune factors","volume":"92","author":"Liu","year":"2021","journal-title":"Seizure - Europ. J. Epilepsy"},{"issue":"6","key":"10.1016\/j.msard.2024.105535_bib0020","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/ene.13618","article-title":"Risk of epilepsy after a single seizure in multiple sclerosis","volume":"25","author":"Mahamud","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105535_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101497","article-title":"Prognostic impact of epilepsy in multiple sclerosis","volume":"38","author":"Mahamud","year":"2020","journal-title":"Mult. Scler. Relat. Disord"},{"issue":"5","key":"10.1016\/j.msard.2024.105535_bib0022","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/ane.13671","article-title":"Temporal trends of epilepsy in multiple sclerosis","volume":"146","author":"Mahamud","year":"2022","journal-title":"Acta. Neurol. Scand."},{"key":"10.1016\/j.msard.2024.105535_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/ijpvm.IJPVM_75_20","article-title":"Prevalence of seizure\/epilepsy in patients with multiple sclerosis: A systematic review and meta-analysis","volume":"12","author":"Mirmosayyeb","year":"2021","journal-title":"Int J Prev Med"},{"issue":"12","key":"10.1016\/j.msard.2024.105535_bib0024","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1111\/epi.17424","article-title":"Acute symptomatic seizures secondary to myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"63","author":"Montalvo","year":"2022","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.msard.2024.105535_bib0025","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00415-020-10346-z","article-title":"Epileptic seizures in multiple sclerosis: Prevalence, competing causes and diagnostic accuracy","volume":"268","author":"Neu\u00df","year":"2021","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105535_bib0026","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10072-016-2803-7","article-title":"Risk factors for unprovoked epileptic seizures in multiple sclerosis: A systematic review and meta-analysis","volume":"38","author":"Gasparini","year":"2017","journal-title":"Neurolog. Sci."},{"issue":"9","key":"10.1016\/j.msard.2024.105535_bib0027","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/epi.17699","article-title":"What is autoimmune encephalitis-associated epilepsy? Proposal of a practical definition","volume":"64","author":"Rada","year":"2023","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.msard.2024.105535_bib0028","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1111\/ene.15551","article-title":"Prognostic impact of epileptic seizures in multiple sclerosis varies according to time of occurrence and etiology","volume":"29","author":"Selton","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105535_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102057","article-title":"Seizure occurrence in myelin oligodendrocyte glycoprotein antibody-associated disease: A systematic review and meta-analysis","volume":"42","author":"Shen","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2024.105535_bib0030","doi-asserted-by":"crossref","unstructured":"Sokic, D. et al. 2001. \u201cSeizures in Multiple Sclerosis\u201d 42 (1).","DOI":"10.1046\/j.1528-1157.2001.48699.x"},{"issue":"7","key":"10.1016\/j.msard.2024.105535_bib0031","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/epi.16571","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions","volume":"61","author":"Steriade","year":"2020","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.msard.2024.105535_bib0032","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple Sclerosis: 2017 revisions of the mcdonald criteria","volume":"17","author":"Thompson, Alan","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105535_bib0033","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.seizure.2013.09.008","article-title":"Prevalence of epilepsy in a cohort of patients with multiple sclerosis","volume":"23","author":"Uribe-San-Mart\u00edn","year":"2014","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.msard.2024.105535_bib0034","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105535_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.msard.2018.11.007","article-title":"Acute epileptic seizures in myelin oligodendrocyte glycoprotein encephalomyelitis and neuromyelitis optica spectrum disorder: A comparative cohort study","volume":"27","author":"Yao","year":"2019","journal-title":"Mult. Scler. Relat. Disord"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:40:37Z","timestamp":1738064437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":35,"alternative-id":["S2211034824001147"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105535","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizures in inflammatory demyelinating disorders of the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105535"}}